174 related articles for article (PubMed ID: 22126905)
1. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
Yin H; Guo R; Xu Y; Zheng Y; Hou Z; Dai X; Zhang Z; Zheng D; Xu H
Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
[TBL] [Abstract][Full Text] [Related]
2. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
Lee E; Kim H; Lee IH; Jon S
J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer.
Xie CY; Xu YP; Jin W; Lou LG
Anticancer Drugs; 2012 Aug; 23(7):698-705. PubMed ID: 22441567
[TBL] [Abstract][Full Text] [Related]
4. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
5. Effect of rapamycin-induced tumor vessel thrombosis combined with docetaxel in non-small-cell lung cancer.
Xu L; Qin Y; Huang J; Qin J; Gu J; Zhu H; Liu H; Cai Y; Wu X; Feng J
Anticancer Drugs; 2013 Apr; 24(4):406-14. PubMed ID: 23411684
[TBL] [Abstract][Full Text] [Related]
6. The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo.
Wang P; Zhang L; Peng H; Li Y; Xiong J; Xu Z
Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4802-8. PubMed ID: 24094190
[TBL] [Abstract][Full Text] [Related]
7. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Lu Z; Wientjes TS; Au JL
Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
[TBL] [Abstract][Full Text] [Related]
8. Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells.
Tamatani T; Ferdous T; Takamaru N; Hara K; Kinouchi M; Kuribayashi N; Ohe G; Uchida D; Nagai H; Fujisawa K; Miyamoto Y
Int J Oncol; 2012 Sep; 41(3):1148-56. PubMed ID: 22766915
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer.
Jung J; Park SJ; Chung HK; Kang HW; Lee SW; Seo MH; Park HJ; Song SY; Jeong SY; Choi EK
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e77-83. PubMed ID: 22795728
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
Lu S; Zhang J; Zhou Z; Liao ML; He WZ; Zhou XY; Li ZM; Xiang JQ; Wang JJ; Chen HQ
Oncol Rep; 2008 Sep; 20(3):581-7. PubMed ID: 18695909
[TBL] [Abstract][Full Text] [Related]
11. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
[TBL] [Abstract][Full Text] [Related]
12. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model.
Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Singh M
Pharm Res; 2006 Sep; 23(9):2094-106. PubMed ID: 16902813
[TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo.
Nishizaki M; Meyn RE; Levy LB; Atkinson EN; White RA; Roth JA; Ji L
Clin Cancer Res; 2001 Sep; 7(9):2887-97. PubMed ID: 11555607
[TBL] [Abstract][Full Text] [Related]
14. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model.
Yin HT; Zhang DG; Wu XL; Huang XE; Chen G
Asian Pac J Cancer Prev; 2013; 14(1):409-12. PubMed ID: 23534763
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel.
Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH
Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1.
Chen J; Lan T; Hou J; Zhang J; An Y; Tie L; Pan Y; Liu J; Li X
Int J Biochem Cell Biol; 2012 May; 44(5):759-69. PubMed ID: 22305890
[TBL] [Abstract][Full Text] [Related]
18. The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.
Agata N; Nogi H; Bamberg M; Milhollen M; Pu M; Weitman S; Kharbanda S; Kufe D
Cancer Chemother Pharmacol; 2005 Dec; 56(6):610-4. PubMed ID: 15947930
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposome-mediated nitric oxide synthase gene therapy enhances the antitumor effects of cisplatin in lung cancer.
Ye S; Yang W; Wang Y; Ou W; Ma Q; Yu C; Ren J; Zhong G; Shi H; Yuan Z; Su X; Zhu W
Int J Mol Med; 2013 Jan; 31(1):33-42. PubMed ID: 23128378
[TBL] [Abstract][Full Text] [Related]
20. Luteolin enhances TNF-related apoptosis-inducing ligand's anticancer activity in a lung cancer xenograft mouse model.
Yan J; Wang Q; Zheng X; Sun H; Zhou Y; Li D; Lin Y; Wang X
Biochem Biophys Res Commun; 2012 Jan; 417(2):842-6. PubMed ID: 22206675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
